Literature DB >> 14645569

Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.

Saeed Shafti-Keramat1, Alessandra Handisurya, Ernst Kriehuber, Guerrino Meneguzzi, Katharina Slupetzky, Reinhard Kirnbauer.   

Abstract

Papillomaviruses replicate in stratified epithelia of skin and mucosa. Infection with certain human papillomavirus (HPV) types is the main cause of anogenital neoplasia, in particular cervical cancer. Early events of papillomavirus infectivity are poorly understood. While heparan sulfate proteoglycans (HSPGs) mediate initial binding to the cell surface, the class of proteins carrying heparan sulfates has not been defined. Here we examined two processes of papillomavirus infection, attachment of virus-like particles (VLP) to cells and infection with authentic HPV type 11 (HPV11) virions. Of the HSPGs, syndecan-1 is the major epithelial form and is strongly upregulated in wound edge keratinocytes. We employed K562 cells, which lack HSPGs except minor amounts of endogenous betaglycan, and stable clones that express cDNAs of syndecan-1, syndecan-4, or glypican-1. Binding of VLP correlated with levels of heparan sulfate on the cell surface. Parental K562 bound HPV16 VLP weakly, whereas all three K562 transfectants demonstrated enhanced binding, with the highest binding capacity observed for syndecan-1-transfected cells, which also expressed the most HSPG. For HPV11 infectivity assays, a high virion inoculum was required to infect K562 cells, whereas ectopic expression of syndecan-1 increased permissiveness eightfold and expression of syndecan-4 or glypican-1 fourfold. Infection of keratinocytes was eliminated by treatment with heparitinase, but not phospholipase C, further implicating the syndecan family of integral membrane proteins as receptor proteins. Human keratinocytes with a homozygous deletion of alpha6 integrin are permissive for HPV11 infection. These results indicate that several HSPGs can serve as HPV receptors and support a putative role for syndecan-1, rather than alpha6 integrin, as a primary receptor protein in natural HPV infection of keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645569      PMCID: PMC296080          DOI: 10.1128/jvi.77.24.13125-13135.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.

Authors:  R B Roden; A Armstrong; P Haderer; N D Christensen; N L Hubbert; D R Lowy; J T Schiller; R Kirnbauer
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Papillomavirus infections--a major cause of human cancers.

Authors:  H zur Hausen
Journal:  Biochim Biophys Acta       Date:  1996-10-09

3.  Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.

Authors:  R Kirnbauer; L M Chandrachud; B W O'Neil; E R Wagner; G J Grindlay; A Armstrong; G M McGarvie; J T Schiller; D R Lowy; M S Campo
Journal:  Virology       Date:  1996-05-01       Impact factor: 3.616

4.  The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells.

Authors:  A Schmitt; A Rochat; R Zeltner; L Borenstein; Y Barrandon; F O Wettstein; T Iftner
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Transmission of human papillomavirus type 11 infection by desquamated cornified cells.

Authors:  J T Bryan; D R Brown
Journal:  Virology       Date:  2001-03-01       Impact factor: 3.616

6.  Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.

Authors:  N D Christensen; J W Kreider; N M Cladel; S D Patrick; P A Welsh
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

Authors:  X S Chen; R L Garcea; I Goldberg; G Casini; S C Harrison
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

8.  In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Authors:  R B Roden; H L Greenstone; R Kirnbauer; F P Booy; J Jessie; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes.

Authors:  P Inki; H Larjava; K Haapasalmi; H M Miettinen; R Grenman; M Jalkanen
Journal:  Eur J Cell Biol       Date:  1994-02       Impact factor: 4.492

10.  Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops.

Authors:  Katharina Slupetzky; Saeed Shafti-Keramat; Petra Lenz; Sabine Brandt; Andreas Grassauer; Margit Sara; Reinhard Kirnbauer
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

View more
  109 in total

1.  Usage of heparan sulfate, integrins, and FAK in HPV16 infection.

Authors:  Cynthia Y Abban; Patricio I Meneses
Journal:  Virology       Date:  2010-05-02       Impact factor: 3.616

2.  Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.

Authors:  Manuela Donalisio; Marco Rusnati; Andrea Civra; Antonella Bugatti; Donatella Allemand; Giovanna Pirri; Andrea Giuliani; Santo Landolfo; David Lembo
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

3.  Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.

Authors:  Timothy D Culp; Lynn R Budgeon; M Peter Marinkovich; Guerrino Meneguzzi; Neil D Christensen
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 4.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

Review 5.  HPV Vaccines: today and in the Future.

Authors:  Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

Review 6.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

7.  Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy.

Authors:  Zurab Surviladze; Rosa T Sterk; Sergio A DeHaro; Michelle A Ozbun
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection.

Authors:  Zurab Surviladze; Rosa T Sterkand; Michelle A Ozbun
Journal:  J Gen Virol       Date:  2015-08       Impact factor: 3.891

Review 9.  [Human papillomavirus infection. Pathology and molecular pathology].

Authors:  K Sotlar
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 10.  Virus movements on the plasma membrane support infection and transmission between cells.

Authors:  Christoph J Burckhardt; Urs F Greber
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.